Latest News & Features
Generics
Lawsuit is second to be filed in Delaware over Abbvie’s Orilissa treatment | Abbive says Teva’s ANDA infringes patent granted in January. 4 April 2023
Americas
Pinsent Masons and Sterne, Kessler, Goldstein, & Fox consider why the Unified Patent Court, due to open on June 1, 2023, will make Europe a more attractive patent litigation venue for US businesses. 4 April 2023
Big Pharma
The three companies will make low-cost versions of HIV PrEP drug | Generics will be available to consumers in 90 low- and middle-income countries. 30 March 2023
Americas
H&H Wholesale Services found to have committed ‘fraud on the court’ | Final amount includes attorneys’ fees and costs. 30 March 2023
Americas
As the US Supreme Court probed the key issue of enablement in Amgen v Sanofi, patent lawyers shared their views on the much-anticipated hearings. 28 March 2023
Biotechnology
Recruit from DLA Piper brings two decades of patent and technical experience in life sciences, biotechnology, and healthcare industries. 28 March 2023
Europe
Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect. 28 March 2023
Big Pharma
NIH rejects petition to use “march-in” rights to allow cheaper competition | Xtandi is “widely available” to public, federal agency says. 23 March 2023
Big Pharma
Hikma label and public statements encouraged infringement, Amarin says | Delaware District Court had dismissed claims label was ‘not skinny enough’. 23 March 2023
Big Pharma
As AbbVie’s multibillion-dollar blockbuster drops over the patent cliff, is it time to tighten up patent and pricing strategies in the US? Sarah Speight investigates. 21 March 2023